The American Society of Hematology (ASH) released a list of common hematology tests, treatments, and procedures that may be unnecessary as part of Choosing Wisely, an initiative of the ABIM Foundation.
RELATED: Hematological Disorders Resource Center
The list includes five evidence-based recommendations to encourage dialogue between patients and physicians about the necessity and potential harm of certain practices.
The following five tests, treatments, and procedures have been identified:
- Limit surveillance CT scans in asymptomatic patients following curative-intent treatment for aggressive lymphoma
- Don’t use inferior vena cava (IVC) filters routinely in patients with acute venous thromboembolism (VTE)
- Do not transfuse more than the minimum number of red blood cell units necessary to relieve symptoms of anemia or to return a patient to a safe hemoglobin range (7–8g/dL in stable, non-cardiac, in-patients)
- Don’t test for thrombophilia in adult patients with VTE occurring in the setting of major transient risk factors (eg, surgery, trauma, prolonged immobility)
- Don’t administer plasma or prothrombin complex concentrates for non-emergent reversal of vitamin K antagonists (eg, outside of the setting of major bleeding, intracranial hemorrhage or anticipated emergent surgery)
The selection process incorporated the guiding principles of avoiding harm, evidence, cost, frequency, and scope of practice.
Tests, procedures, or treatments considered as increasing risk of harm were prioritized for inclusion on ASH’s Choosing Wisely list.
For more information call (202) 776-0544 or visit ASH’s Choosing Wisely list.